Sun Pharmaceutical Industries has made a significant move in its longstanding pursuit to acquire Taro Pharmaceutical Industries. The Indian drugs giant aims to purchase all of Taro's remaining shares through a reverse triangular merger, marking a crucial step towards consolidating its control over the company. The proposal has generated enthusiasm in the market, with investors optimistic about the potential liquidity opportunity it presents.